Martina Guerrero
Featured publications
-
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Authors:Reference: EUROPEAN RESPIRATORY JOURNAL. -
DECIPHERING THE IMPACT OF IDELALISIB ON FOLLICULAR LYMPHOMA AND ITS IMMUNE MICROENVIRONMENT
Authors:Reference: HAEMATOLOGICA. -
Blood ammonia and lactate as markers of muscle metabolites during leg press exercise
Authors:Reference: JOURNAL OF STRENGTH AND CONDITIONING RESEARCH. -
Upregulation of heart PFK-2/FBPase-2 isozyme in skeletal muscle after persistent contraction
Authors:Reference: PFLUGERS ARCHIV EUROPEAN JOURNAL OF PHYSIOLOGY. -
Hexokinase 2, Glycogen Synthase and Phosphorylase Play a Key Role in Muscle Glycogen Supercompensation
Authors:Reference: PLOS ONE. -
Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study
Authors:Reference: PLOS ONE 2016. -
Predicting In-Hospital Treatment Failure (</=7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids
Authors:Reference: COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2016. -
Identification of lysosomal Npc1-Binding Proteins: Cathepsin D activity is regulated by NPC1
Authors:Reference: PROTEOMICS 2016. -
C-Reactive Protein at Discharge, Diabetes Mellitus and >= 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Authors:Reference: COPD: JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2015. -
The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations
Authors:Reference: Febs Journal 2014.